General Announcement::Glenmark launches Ryaltris -AZ at an affordable price in India

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
03-May-2021 12:42:46
Status
New
Announcement Sub Title
Glenmark launches Ryaltris -AZ at an affordable price in India
Announcement Reference
SG210503OTHRLXE3
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
03/05/2021 00:00:00
Description (Please provide a detailed description of the event in the box below)
Glenmark launches Ryaltris -AZ at an affordable price in India

Attachments

SGX PR_03052021.pdf
Total size =1114K